Patents by Inventor Maytal Piran

Maytal Piran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid state forms of Omecamtiv mecarbil and Omecamtiv mecarbil diHCl
    Patent number: 11608318
    Abstract: The present disclosure relates to solid state forms of Omecamtiv mecarbil and Omecamtiv mecarbil diHCl, processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: July 11, 2019
    Date of Patent: March 21, 2023
    Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
    Inventors: Elvira Haimov, Doron Rudik, Maytal Piran
  • Crystalline polymorphs of Pracinostat and Pracinostat salts
    Patent number: 11465974
    Abstract: The present disclosure encompasses crystalline polymorphs of Pracinostat and of Pracinostat salts, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: October 11, 2022
    Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
    Inventors: Jenny Goldshtein, Maytal Piran, Doron Rudik, Rotem Sella-Erez, Sharona Alfasie Shachan-Tov, Ofir Shaul
  • Crystalline form E1 of larotrectinib ethanesulfonate
    Patent number: 11339164
    Abstract: Salts and solid state forms of Larotrectinib, processes for preparation thereof, pharmaceutical compositions thereof, and uses thereof are disclosed.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: May 24, 2022
    Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
    Inventors: Sharona Shachan-Tov, Doron Rudik, Oshrat Frenkel, Rotem Sella-Erez, Maytal Piran, Ido Fuchs
  • SOLID STATE FORMS OF VALBENAZINE
    Publication number: 20220127259
    Abstract: Solid state forms of Valbenazine, Valbenazine salts, processes for preparation thereof and pharmaceutical compositions thereof are disclosed. Processes for the preparation of Valbenazine and intermediates in the preparation thereof are further described.
    Type: Application
    Filed: January 5, 2022
    Publication date: April 28, 2022
    Inventors: Ariel Mittelman, Sharona Shachan-Tov, Abed Masarwa, Rotem Sella-Erez, Jonathan Enav, Motti Erlich, Victoria Machtey, Maytal Piran, Marina Yarovoy, Sagit Azran, Einat Kisin-Finfer, Tamar Nidam
  • Solid state forms of valbenazine
    Patent number: 11242341
    Abstract: Solid state forms of Valbenazine, Valbenazine salts, processes for preparation thereof and pharmaceutical compositions thereof are disclosed. Processes for the preparation of Valbenazine and intermediates in the preparation thereof are further described.
    Type: Grant
    Filed: October 6, 2017
    Date of Patent: February 8, 2022
    Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
    Inventors: Ariel Mittelman, Sharona Shachan-Tov, Abed Masarwa, Rotem Sella-Erez, Jonathan Enav, Motti Erlich, Victoria Machtey, Maytal Piran, Marina Yarovoy, Sagit Azran, Einat Kisin-Finfer, Tamar Nidam
  • SOLID STATE FORMS OF OMECAMTIV MECARBIL & OMECAMTIV MECARBIL DIHCL
    Publication number: 20210317085
    Abstract: The present disclosure relates to solid state forms of Omecamtiv mecarbil and Omecamtiv mecarbil diHCl, processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: July 11, 2019
    Publication date: October 14, 2021
    Inventors: Elvira Haimov, Doron Rudik, Maytal Piran
  • CRYSTALLINE POLYMORPHS OF PRACINOSTAT AND PRACINOSTAT SALTS
    Publication number: 20210087150
    Abstract: The present disclosure encompasses crystalline polymorphs of Pracinostat and of Pracinostat salts, and pharmaceutical compositions thereof.
    Type: Application
    Filed: December 19, 2018
    Publication date: March 25, 2021
    Inventors: Jenny Goldshtein, Maytal Piran, Doron Rudik, Rotem Sella-Erez, Sharona Alfasie Shachan-Tov, Ofir Shaul
  • SALTS AND SOLID STATE FORMS OF LAROTRECTINIB
    Publication number: 20200255435
    Abstract: Salts and solid state forms of Larotrectinib, processes for preparation thereof, pharmaceutical compositions thereof, and uses thereof are disclosed.
    Type: Application
    Filed: October 31, 2018
    Publication date: August 13, 2020
    Applicants: ASSIA CHEMICAL INDUSTRIES LTD., ASSIA CHEMICAL INDUSTRIES LTD.
    Inventors: Sharona Shachan-Tov, Doron Rudik, Oshrat Frenkel, Rotem Sella-Erez, Maytal Piran, Ido Fuchs
  • SOLID STATE FORMS OF VALBENAZINE
    Publication number: 20200048244
    Abstract: Solid state forms of Valbenazine, Valbenazine salts, processes for preparation thereof and pharmaceutical compositions thereof are disclosed. Processes for the preparation of Valbenazine and intermediates in the preparation thereof are further described.
    Type: Application
    Filed: October 6, 2017
    Publication date: February 13, 2020
    Inventors: Ariel Mittelman, Sharona Shachan-Tov, Abed Masarwa, Rotem Sella-Erez, Jonathan Enav, Motti Erlich, Victoria Machtey, Maytal Piran, Marina Yarovoy, Sagit Azran, Einat Kisin-Finfer, Tamar Nidam
  • Nilotinib salts and crystalline forms thereof
    Patent number: 9090598
    Abstract: Nilotinib salts and crystalline forms thereof have been prepared and characterized.
    Type: Grant
    Filed: November 12, 2014
    Date of Patent: July 28, 2015
    Assignee: Teva Pharmaceutical Industries, LTD.
    Inventors: Maytal Piran, Jacob Rendell
  • Nilotinib Salts And Crystalline Forms Thereof
    Publication number: 20150099885
    Abstract: Nilotinib salts and crystalline forms thereof have been prepared and characterized.
    Type: Application
    Filed: November 12, 2014
    Publication date: April 9, 2015
    Inventors: Maytal PIRAN, Jacob RENDELL
  • Nilotinib salts and crystalline forms thereof
    Patent number: 8937082
    Abstract: Nilotinib salts and crystalline forms thereof have been prepared and characterized.
    Type: Grant
    Filed: June 21, 2011
    Date of Patent: January 20, 2015
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Maytal Piran, Jacob Rendell
  • Crystalline forms of febuxostat
    Patent number: 8742129
    Abstract: New forms of Febuxostat have bean, prepared and characterized. These forms are useful for examples in the chronic management of hyperuricemia in patients with gout.
    Type: Grant
    Filed: March 1, 2013
    Date of Patent: June 3, 2014
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Maytal Piran, Leonid Metsger
  • Crystalline forms of Febuxostat
    Patent number: 8609856
    Abstract: New forms of Febuxostat have been prepared and characterized. These forms are useful, for example, in the chronic management of hyperuricemia in patients with gout.
    Type: Grant
    Filed: March 1, 2013
    Date of Patent: December 17, 2013
    Assignee: Teva Pharmaceuticals USA, Inc.
    Inventors: Maytal Piran, Leonid Metsger
  • Nilotinib HCl crystalline forms
    Patent number: 8592442
    Abstract: Crystalline forms of Nilotinib HCl are described.
    Type: Grant
    Filed: June 27, 2012
    Date of Patent: November 26, 2013
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Greta Sterimbaum, Sigalit Levi, Adi Yeori, Tamas Koltai, Valerie Niddam-Hildesheim, Maytal Piran, Shay Asis, Hagit Eisen-Nevo, David Malcolm Crowe
  • CRYSTALLINE FORMS OF FEBUXOSTAT
    Publication number: 20130245077
    Abstract: New forms of Febuxostat have bean, prepared and characterized. These forms are useful for examples in the chronic management of hyperuricemia in patients with gout.
    Type: Application
    Filed: March 1, 2013
    Publication date: September 19, 2013
    Applicant: TEVA PHARMACEUTICALS INDUSTRIES LTD.
    Inventors: Maytal PIRAN, Leonid METSGER
  • NILOTINIB SALTS AND CRYSTALLINE FORMS THEREOF
    Publication number: 20130158059
    Abstract: Nilotinib salts and crystalline forms thereof have been prepared and characterized.
    Type: Application
    Filed: June 21, 2011
    Publication date: June 20, 2013
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Maytal Piran, Jacob Rendell
  • NILOTINIB HCL CRYSTALLINE FORMS
    Publication number: 20130096304
    Abstract: Crystalline forms of Nilotinib HCl are described.
    Type: Application
    Filed: June 27, 2012
    Publication date: April 18, 2013
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Greta Sterimbaum, Sigalit Levi, Adi Yeori, Tamas Koltai, Valerie Niddam-Hildesheim, Maytal Piran, Shay Asis, Hagit Eisen-Nevo, David Malcolm Crowe
  • Crystalline form of febuxostat
    Patent number: 8415481
    Abstract: New forms of Febuxostat have been prepared and characterized. These forms are useful, for example, in the chronic management of hyperuricemia in patients with gout.
    Type: Grant
    Filed: June 10, 2010
    Date of Patent: April 9, 2013
    Assignee: Teva Pharmaceuticals USA, Inc.
    Inventors: Maytal Piran, Leonid Metsger
  • Nilotinib HCl crystalline forms
    Patent number: 8227477
    Abstract: Crystalline forms of Nilotinib HCl are described.
    Type: Grant
    Filed: November 5, 2009
    Date of Patent: July 24, 2012
    Inventors: Greta Sterimbaum, Sigalit Levi, Adi Yeori, Tamas Koltai, Valerie Niddam-Hildesheim, Maytal Piran, Shay Asis, Hagit Eisen-Nevo, David Malcolm Crowe